Brantford, Canada

Sammy Chris Duncan

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Ontario, CA (2008)
  • Brantford, CA (2009 - 2017)

Company Filing History:


Years Active: 2008-2017

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Sammy Chris Duncan: Innovator in Pharmaceutical Processes

Introduction

Sammy Chris Duncan is a notable inventor based in Brantford, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of complex chemical compounds. With a total of 5 patents to his name, Duncan's work has had a meaningful impact on the industry.

Latest Patents

Duncan's latest patents include innovative processes for the preparation of 3-alkyl indoles. This invention provides methods for synthesizing 3-alkyl indoles of specific formulas, which are crucial in various chemical applications. Another significant patent involves methods of making Lubiprostone and its intermediates. This patent outlines processes for preparing Lubiprostone, along with compounds and intermediates essential for its synthesis.

Career Highlights

Throughout his career, Duncan has worked with Apotex Pharmachem Inc., a leading company in the pharmaceutical sector. His expertise in chemical processes has been instrumental in advancing the company's research and development efforts.

Collaborations

Duncan has collaborated with several professionals in his field, including Yajun Zhao and Bhaskar Reddy Guntoori. These collaborations have fostered innovation and contributed to the successful development of his patented processes.

Conclusion

Sammy Chris Duncan's contributions to pharmaceutical innovations through his patents demonstrate his commitment to advancing chemical processes. His work continues to influence the industry and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…